Schedule 13G ownership disclosure

PDL BIOPHARMA INC

Security class unavailable · CUSIP: 69329Y104

Event date: 2020-08-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-20-000913
Form type
SC 13G
Filer
PDL BIOPHARMA, INC.
CIK
CIK 882104
Filed
Aug 28, 2020
Reporting period
Aug 18, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub